Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Arch Therapeutics, Inc. (ARTH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/05/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
10/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
09/27/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
08/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/22/2023 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/09/2023 |
SC 13G
| Stahl Andrew reports a 9.9% stake in Arch Therapeutics, Inc. |
08/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
07/25/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/24/2023 |
8-K
| Quarterly results |
07/14/2023 |
SC 13G
| BIGGER CAPITAL FUND L P reports a 9.9% stake in Arch Therapeutics, Inc. |
07/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events Interactiv... |
07/12/2023 |
SC 13G
| Oasis Capital, LLC reports a 10% stake in Arch Therapeutics, Inc. |
07/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
04/20/2023 |
8-K
| Quarterly results |
03/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
03/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
01/30/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
01/27/2023 |
SC 13G/A
| Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc. |
01/25/2023 |
SC 13G/A
| Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc. |
01/23/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
01/17/2023 |
8-K
| Quarterly results |
12/28/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
12/02/2022 |
8-K
| Quarterly results |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
09/30/2022 |
8-K
| Quarterly results |
08/31/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|
|
|